Small vessel disease in patients with subarachnoid hemorrhage: Prevalence and associations with vasospasm occurrence,severity and clinical outcomes

Abstract

Purpose

Investigating the associations between cerebral small vessel disease (cSVD) burden and cerebral vasospasm (CVS), delayed cerebral ischemia (DCI) and clinical outcomes in patients with aneurysmal subarachnoid hemorrhage (aSAH).

Methods

Consecutive aSAH patients with initial (<7 days after onset) and 3-month follow-up brain magnetic resonance imaging (MRI) and clinical evaluation at 6 months were included. The cSVD burden score was built using MRI criteria. CVS was defined according to transcranial Doppler examination and computed tomography (CT) or digital subtraction angiography. DCI was defined by the appearance of hyperintense fluid-attenuated inversion recovery lesions, with territorial or cortico-subcortical distribution, between initial MRI and 3-month MRI. The modified Rankin scale of ≤2 at 6 months was considered a favorable outcome. Using univariate and multivariable analyses, we investigated the associations between cSVD and CVS, DCI and clinical outcome.

Results

A total of 113 patients were included in the study sample (median age 49.1 years (IQR 42.1–60.8), 70/113 females). The burden of cSVD was mild with a median of 0 (IQR 0–1). When comparing patients with no/mild versus those with moderate/severe cSVD burden, we did not find a univariable difference regarding vasospasm occurrence (60% versus 46.1%, p = 0.54), DCI (20.2% versus 23%, p = 0.66) or favorable outcome at 3 months (94% versus 83.3%, p = 0.20). There was a univariable trend towards more frequent favorable outcome in patients with no/milde white matter hyperintensities versus those with moderate/severe white matter hyperintensities (92% versus 85%, p = 0.09). In multivariable models, cSVD markers were not associated with CVS occurrence and severity, DCI or clinical outcome.

Conclusions

In patients with mild aSAH, the burden of cSVD as assessed by MRI is minimal and is not associated with CVS, DCI or clinical outcome.

Keywords

Cerebral small vessel disease aneurysmal subarachnoid hemorrhage cerebral vasospasm delayed cerebral ischemia clinical outcome

Get full access to this article

View all access options for this article.

References

Staals

Makin

SDJ

Doubal

, et al. Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden. Neurology 2014; 83: 1228–1234.

Wardlaw

Smith

Biessels

, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013; 12: 822–838.

Lau

Schulz

, et al. Total small vessel disease score and risk of recurrent stroke: validation in 2 large cohorts. Neurology 2017; 88: 2260–2267.

Schulz

Grüter

Briley

, et al. Leukoaraiosis and increased cerebral susceptibility to ischemia: lack of confounding by carotid disease. J Am Heart Assoc 2013; 2: e000261.

Etminan

Macdonald

. Management of aneurysmal subarachnoid hemorrhage. Handb Clin Neurol 2017; 140: 195–228.

Fragata

Alves

Papoila

, et al. Computed tomography perfusion as a predictor of delayed cerebral ischemia and functional outcome in spontaneous subarachnoid hemorrhage: a single center experience. Neuroradiol J 2019; 32: 179–188.

Inagawa

. Risk factors for cerebral vasospasm following aneurysmal subarachnoid hemorrhage: a review of the literature. World Neurosurg 2016; 85: 56–76.

Fragata

Alves

Papoila

, et al. Early prediction of delayed ischemia and functional outcome in acute subarachnoid hemorrhage: role of diffusion tensor imaging. Stroke 2017; 48: 2091–2097.

Etherton

Cougo

, et al. Structural integrity of normal appearing white matter and sex-specific outcomes after acute ischemic stroke. Stroke 2017; 48: 3387–3389.

10.

Hunt

Hess

. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 1968; 28: 14–20.

11.

Frontera

Claassen

Schmidt

, et al. Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified Fisher scale. Neurosurgery 2006; 59: 21–27. discussion 21–27.

12.

Bretz

Von Dincklage

Woitzik

, et al. The Hijdra scale has significant prognostic value for the functional outcome of Fisher grade 3 patients with subarachnoid hemorrhage. Clin Neuroradiol 2017; 27: 361–369.

13.

Connolly

Rabinstein

Carhuapoma

, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2012; 43: 1711–1737.

14.

Charidimou

Meegahage

Fox

, et al. Enlarged perivascular spaces as a marker of underlying arteriopathy in intracerebral haemorrhage: a multicentre MRI cohort study. J Neurol Neurosurg Psychiatry 2013; 84: 624–629.

15.

Boulouis

Charidimou

Jessel

, et al. Small vessel disease burden in cerebral amyloid angiopathy without symptomatic hemorrhage. Neurology 2017; 88: 878–884.

16.

Pasquier

Leys

Weerts

JGE

, et al. Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts. Eur Neurol 1996; 36: 268–272.

17.

Aaslid

Huber

Nornes

. Evaluation of cerebrovascular spasm with transcranial Doppler ultrasound. J Neurosurg 1984; 60: 37–41.

18.

Soustiel

Shik

Shreiber

, et al. Basilar vasospasm diagnosis: investigation of a modified “Lindegaard Index” based on imaging studies and blood velocity measurements of the basilar artery. Stroke 2002; 33: 72–77.

19.

Kivisaari

Salonen

Servo

, et al. MR imaging after aneurysmal subarachnoid hemorrhage and surgery: a long-term follow-up study. Am J Neuroradiol 2001; 22: 1143–1148.

20.

D’Souza

Gorthi

Vadwala

, et al. Diffusion tensor tractography in cerebral small vessel disease: correlation with cognitive function. Neuroradiol J 2018; 31: 83–89.

21.

Pantoni

. Pathophysiology of age-related cerebral white matter changes. Cerebrovasc Dis 2002; 13(Suppl 2): 7–10.

22.

Bashir

Andresen

Bartek

, et al. Intra-arterial nimodipine for cerebral vasospasm after subarachnoid haemorrhage: influence on clinical course and predictors of clinical outcome. Neuroradiol J 2016; 29: 72–81.

23.

Naranjo

Arkuszewski

Rudzinski

, et al. Brain ischemia in patients with intracranial hemorrhage: pathophysiological reasoning for aggressive diagnostic management. Neuroradiol J 2013; 26: 610–628.

24.

Brisset

Boutouyrie

Pico

, et al. Large-vessel correlates of cerebral small-vessel disease. Neurology 2013; 80: 662–669.